Navigation Links
ONCOLOGY and the Cancer Network Launch "Consultations in Ethics" Feature

NORWALK, Conn., Sept. 5, 2012 /PRNewswire/ -- Oncologists regularly struggle with difficult ethical issues in the course of daily practice. To help them respond more confidently to the ethical dilemmas they encounter, UBM Medica US has launched a new feature, "Consultations in Ethics," both in the journal ONCOLOGY and on the Cancer Network.

"Consultations in Ethics" presents actual cases submitted by oncologists, along with discussion of the ethical issues involved. The case reviews are provided by Dr. Paul R. Helft, director of the Charles Warren Fairbanks Center for Medical Ethics at Indiana University Health in Indianapolis and a member of ONCOLOGY's Editorial Board.

The inaugural cases and consultations include explorations of issues such as these:

  • A patient insists that you explore unproven alternative therapies for his metastatic colon cancer. Are you obliged to discuss these with him?
  • How should you treat a squamous cell carcinoma on the vocal cord in a patient with advanced dementia, no surviving relatives, and no advance directives?
  • Should you inform your patient's employer that the patient insists on continuing to work despite being told that her ability to do her job safely will be compromised by the opiates she is receiving for pain?

Because arriving at a resolution to an ethical dilemma is often facilitated by discussion with others and consideration of the situation from a variety of perspectives, readers are encouraged to comment on the case discussions on the Cancer Network. Visitors to the site are already adding their thoughts on the feature's first cases.

Readers are also invited to submit cases. Names and identifying details will be changed in any case selected for use in the feature so as to ensure protection of privacy.

About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include,,,,,, and UBM Medica US is part of UBM Connect – which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit           

Media contact:
Jason J. Golden
Content Marketing Manager

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Agendia Brings Together Thought Leaders in Molecular Diagnostics and Medical Oncology
2. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
3. Champions Oncology Reports Resignation Of Director
4. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
5. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
6. Radiation Therapy in Oncology Drug Pipeline Update 2012
7. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
8. Schulman Associates IRB offers oncology-focused review board
9. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
10. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
11. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
Post Your Comments:
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
Breaking Medicine News(10 mins):